921145-23-5

Basic information

• Product Name: 2-(Chloromethyl)-5-methyl-1,3-thiazole hydrochloride
• Synonyms: 2-(Chloromethyl)-5-methyl-1,3-thiazole hydrochloride;2-(chloromethyl)-5-methyl-1,3-thiazole
• CAS NO: 921145-23-5
• Molecular Formula: C₅H₆ClNS
• Molecular Weight: 184.08678
• Mol File: 921145-23-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 199.9±23.0 °C(Predicted)
• Appearance: /
• Density: 1.271±0.06 g/cm3(Predicted)
• PKA: 2.48±0.10(Predicted)
• CAS DataBase Reference: 2-(Chloromethyl)-5-methyl-1,3-thiazole hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(Chloromethyl)-5-methyl-1,3-thiazole hydrochloride(921145-23-5)
• EPA Substance Registry System: 2-(Chloromethyl)-5-methyl-1,3-thiazole hydrochloride(921145-23-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 921145-23-5(Hazardous Substances Data)

Usage

General Description

2-(Chloromethyl)-5-methyl-1,3-thiazole hydrochloride is a chemical compound with the molecular formula C5H7ClN2S.HCl. It is an organic compound that contains a thiazole ring with a chloromethyl group and a methyl group. 2-(Chloromethyl)-5-methyl-1,3-thiazole hydrochloride is often used as a reagent in organic synthesis and is known for its antimicrobial and antifungal properties. It is commonly used in pharmaceutical industries for the synthesis of various drugs and is also employed in the production of agrochemicals. Additionally, it has potential applications in the field of veterinary medicine and is used as a preservative in food and beverage industries.

Upstream product

• 13838-78-3 5-methyl-1,3-thiazole-2-carbaldehyde 
• 202932-04-5 (5-methyl-1,3-thiazol-2-yl)methanol 

Relevant articles and documents

SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF

Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.

SUBSTITUTED PYRIDINE DERIVATIVES AS FABI INHIBITORS

The present invention provides substituted pyridine derivatives of formula (I), which may be therapeutically useful as as anti-bacterial agents, more particulalrly FabI inhibitors. Formula(I) in which R1 to R5 and L have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention in diseases or disorder, in particular their use in diseases or disorder where there is an advantage anti-bacterial agents, more particularly FabI inhibitors. The present invention also provides methods for synthesizing and administering the FabI inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the FabI inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor.